b'Professor Jeremy Webb, NBIC Southampton Co-DirectorJeremy Webb is Professor of Microbiology at the University of Southampton. His work focuses on the adaptive biology, antimicrobial resistance, evolution, and molecular genetics of biofilms and polymicrobial communities. His work includes discoveries in the regulation and control of biofilm dispersal, which are now being exploited for therapeutic applications in cystic fibrosis, including the first human clinical trial for a biofilm-targeted therapeutic. Current research also seeks to identify genes that undergo adaptive evolution during bacterial biofilm development.Dr Mark Richardson, NBIC CEOMark joined NBIC on its formation in December 2017 having worked for over 30 years in R&D in the medical device industry, leading projects and global teams. He led the Global Innovation Team for Smith+Nephew Wound Management from 2000-2002, and then formed and led their approaches to open innovation, including engaging with Innovation Knowledge Centres in the UK.Mark gained his degree in microbiology at the University of Leeds followed by an MSc and PhD in biochemistry from the University of Birmingham. He also has an MBA from the Open University.Dr Jo Slater-Jefferies, NBIC Operations DirectorJo joined NBIC in April 2018 and is also the Associate Dean of Enterprise for the Faculty of Environmental and Life Sciences at the University of Southampton. Jo has been a Director and Trustee of the Asthma, Allergy and Inflammation Research (AAIR) charity since 2011. She started her scientific career as a Senior Scientist and Quality Manager at Sciona Ltd, a spin-out company combining lifestyle data and genetic analysis. Between 2011 and 2018 she held the position of General Manager for EpiGen, a global research consortium.Jo holds a BSc Honours in molecular biology and an industrial sponsored PhD from the University of Portsmouth. In 2014, Jo received an MBA, and in 2017 became a Chartered Manager at the Chartered Management Institute.7'